1. Home
  2. TRVI vs RUN Comparison

TRVI vs RUN Comparison

Compare TRVI & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

SELL

Current Price

$13.31

Market Cap

1.9B

Sector

Health Care

ML Signal

SELL

Logo Sunrun Inc.

RUN

Sunrun Inc.

SELL

Current Price

$8.18

Market Cap

2.1B

Sector

Miscellaneous

ML Signal

SELL

Company Overview

Basic Information
Metric
TRVI
RUN
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
TRVI
RUN
Price
$13.31
$8.18
Analyst Decision
Strong Buy
Buy
Analyst Count
11
19
Target Price
★ $28.18
$13.59
AVG Volume (30 Days)
1.5M
★ 11.0M
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
31.91
★ 113.35
EPS
N/A
★ 1.60
Revenue
N/A
★ $858,578,000.00
Revenue This Year
N/A
$19.80
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.42
Revenue Growth
N/A
★ 12.97
52 Week Low
$9.82
$6.78
52 Week High
$20.22
$21.95

Technical Indicators

Market Signals
Indicator
TRVI
RUN
Relative Strength Index (RSI) 46.10 48.05
Support Level $13.00 $6.94
Resistance Level $13.55 $9.17
Average True Range (ATR) 0.88 0.67
MACD 0.06 -0.00
Stochastic Oscillator 20.92 31.44

Price Performance

Historical Comparison
TRVI
RUN

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

Share on Social Networks: